- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 17.72M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $94.12M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $197.38M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $113.07M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $34.67M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $75.93M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $124.01M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $34.22M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $45.38M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $131.34M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $248.98M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $286.56M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $258.22M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $301.21M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $275.8M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 3.39K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $354K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$45.91M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $93.2M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $122.89M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$11.77 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$11.77 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $11.44M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $12.64M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$39.94M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$36.91M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $8.22M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $19.95M |
| Revenue | Q1 2025 · Mar 31, 2024 | $28.17M |